Patent Trial and Appeal Board Reform Act of 2022

Software copyright and related policy issues. Software patents and related policy issues. S. 2891, Restoring the America Invents Act. S. 4417, Patent Trial and Appeal Board Reform Act of 2022. S. 2774, Pride in the Patent Ownership Act. S. 2773, Unleashing American Innovators Act. Copyright Office modernization. H.R. 5374, SHOP SAFE Act. S. 3880, Strengthening Measures to Advance Rights Technologies (SMART) Copyright Act of 2022. S. 4734, Patent Eligibility Restoration Act of 2022.

Client expense: $2,300,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR)

Software copyright and related policy issues. Software patents and related policy issues. S. 2891, Restoring the America Invents Act. S. 4417, Patent Trial and Appeal Board Reform Act of 2022. S. 2774, Pride in the Patent Ownership Act. S. 2773, Unleashing American Innovators Act. Subject matter eligibility under patent law. Copyright Office modernization. H.R. 5374, SHOP SAFE Act. S. 3880, Strengthening Measures to Advance Rights Technologies (SMART) Copyright Act of 2022.

Client expense: $2,410,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR)

I have discussed patent eligibility issues and potential amendments to 35 USC 101, including S.4734 (the Patent Eligibility Restoration Act of 2022). I have also discussed potential amendments to the inter partes review process (35 USC 311 et seq), including those proposed in previous Congresses, e.g., S.2082 and H.R.3666 (STRONGER Patents Act of 2019). I have also addressed some of the provisions relating to patent litigation contained in these two bills (such as the abrogation of the holding in eBay v. MercExchange). I have discussed discretionary denials of institution by the Patent Trial and Appeals Board (PTAB) and potential remedies for the potential Appointments Clause problem for the PTAB, which are addressed in S.2891 (Restoring the America Invents Act). I have also discussed general patent quality issues and the funding of the U.S. Patent and Trademark through fees, which do not relate directly (for now) to any particular bill. I have also discussed the mandatory recordation of patent assignments as addressed in S.2774 (Pride in Patent Ownership Act). Finally, I have discussed efforts to expand innovation and patenting to be more inclusive of persons with diverse backgrounds, including two bills that would authorize the Patent and Trademark Office to collect certain voluntarily-submitted demographic information: e.g., H.R.1723 and S.632 (the IDEA Act) and one that would take a variety of other actions to expand American innovation: S.2773 (Unleashing American Innovators Act of 2021). Additionally, I have advocated against H.R.5874 - the Restoring Americas Leadership in Innovation Act of 2021 and in favor of S.4417 - the Patent Trial and Appeal Board Reform Act of 2022.

Client expense: Not reported · Firm income: $99,000

Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, White House Office

Monitor issues related to patent policy, including Advancing America's Interest Act, H.R. 5184, Restoring the America Invents Act, S. 2891, and the Patent Trial and Appeals Board Reform Act (S.4417).

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to patent policy, including the Patent Trial and Appeal Board Reform Act of 2022 (S.4417).

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to patent policy and reform, including Restoring the America Invents Act, S. 2891 and the Patent Trial and Appeal Board Reform Act of 2022, S.4417.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

Monitor issues related to reforms of patent law, including the Patent Trial and Appeal Board Reform Act of 2022 (S.4417).

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Intellectual Property; issues related to S.4417 "Patent Trial and Appeal Board Reform Act of 2022"; and issues related to S.2774 "Pride in Patent Ownership Act".

Client expense: $870,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1723 - Inventor Diversity for Economic Advancement (IDEA) Act S. 632 - Inventor Diversity for Economic Advancement (IDEA) Act S. 2774 - Pride in Patent Ownership (PPO) Act S. 4417 - Patent Trial and Appeal Board (PTAB) Reform Act -- regarding policy issues affecting higher education institutions and their faculty and students

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Software copyright and related policy issues. Software patents and related policy issues. S. 2891, Restoring the America Invents Act. S. 4417, Patent Trial and Appeal Board Reform Act of 2022. S. 2774, Pride in the Patent Ownership Act. S. 2773, Unleashing American Innovators Act. Copyright Office modernization. H.R. 5374, SHOP SAFE Act. S. 3880, Strengthening Measures to Advance Rights Technologies (SMART) Copyright Act of 2022. S. 4734, Patent Eligibility Restoration Act of 2022.

Client expense: $2,540,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR)

Patent Settlements. Patent Abuse. Skinny Labeling. Inter Partes Review. Impact of IPR decisions on 30-month stay. IPR Amendments. Enhancing Quality of Patents through the PTAB. S.2891: Restoring the America Invents Act. S.4417: Patent Trial and Appeal Board Reform Act of 2022. S.4430: Interagency Patent Coordination and Improvement Act of 2022. S.4704: Patent Examination and Quality Improvement Act of 2022. H.R.6381/S.3521: CREATE Act of 2022.

Client expense: $900,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE

H.R. 1629: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs H.R. 2148: Prescription Drug Price Relief Act of 2021 - Provisions related to prescription drug pricing and march-in rights H.R. 2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 - Provisions related to intellectual property and patents H.R. 2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act - Provisions related to patent infringement H.R. 2891: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements H.R. 5635: Intellectual Property Violators Accountability and Transparency Act - Provisions related to intellectual property protections H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021 - Provisions related to intellectual property protections S. 250: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs S. 415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity (Public Law 117-9) - Provisions related to FDA policy and exclusivity S. 1428: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements S. 1435: Affordable Prescriptions for Patients Act of 2021 - Provisions related to intellectual property and patents S. 2773: Unleashing American Innovators Act or 2021 - Provisions related to USPTO policy S. 2774: Pride in Patent Ownership Act - Provisions related to patent transparency S. 2891: Restoring the America Invents Act - A bill to amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 2910: Expanding Access to Low-Cost Generics Act of 2021 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes S. 4417: Patent Trial and Appeal Board Reform Act of 2022 - To amend title 35, United States Code, to address matter relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4704: Patent Examination and Quality Improvement Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Biopharmaceutical innovation and patent policy issues Bayh-Dole march-in rights policy issues

Client expense: $860,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

H.R. 1629: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs H.R. 2148: Prescription Drug Price Relief Act of 2021 - Provisions related to prescription drug pricing and march-in rights H.R. 2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 - Provisions related to intellectual property and patents H.R. 2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act - Provisions related to patent infringement H.R. 2891: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements H.R. 5635: Intellectual Property Violators Accountability and Transparency Act - Provisions related to intellectual property protections H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021 - Provisions related to intellectual property protections S. 250: Fairness in Orphan Drug Exclusivity Act - Provisions related to FDA policy and orphan drugs S. 415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity (Public Law 117-9) - Provisions related to FDA policy and exclusivity S. 1428: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements S. 1435: Affordable Prescriptions for Patients Act of 2021 - Provisions related to intellectual property and patents S. 2773: Unleashing American Innovators Act of 2021 - Provisions related to USPTO policy S. 2774: Pride in Patent Ownership Act - Provisions related to patent transparency S. 2891: Restoring the America Invents Act - A bill to amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 2910: Expanding Access to Low-Cost Generics Act of 2021 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes S. 4417: Patent Trial and Appeal Board Reform Act of 2022 - To amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4704: Patent Examination and Quality Improvement Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Biopharmaceutical innovation and patent policy issues Bayh-Dole march-in rights policy issues

Client expense: $6,610,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

S. 2891, Restoring the America Invents Act; S. 2774, Pride in the Patent Ownership Act; S. 2773, Unleashing American Innovators Act. H.R. 5374, SHOP SAFE Act; S.3880, SMART Copyright Act of 2022; S.4417 Patent Trial and Appeal Board Reform Act of 2022; S. 4734, Patent Eligibility Restoration Act of 2022 Software copyright and related policy issues. Software patents and related policy issues. Subject matter eligibility under patent law. Matters related to the US Copyright Office. Review of the Digital Millenium Copyright Act. Administrative review proceedings under the America Invents Act. Copyright office modernization.

Client expense: $1,330,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR)

Patent Eligibility Restoration Act (S.4734) Restoring Americas Leadership in Innovation Act (H.R.5874) Unleashing American Innovators Act (S.2773/H.R.8697) Inventor Diversity for Economic Advancement Act (S.632/H.R.1723) Patent Examination and Quality Improvement Act (S.4704) Patent Trial and Appeal Board Reform Act (S.4417) Pride in Patent Ownership Act (S.2774)

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021; All provisions of the bill. S. 2774: Pride in Patent Ownership Act; All provisions of the bill. S. 4417: Patent Trial and Appeal Board Reform Act of 2022; All provisions of the bill. S. 4734: Patent Eligibility Restoration Act of 2022; All provisions of the bill.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021; All provisions of the bill. S. 2774: Pride in Patent Ownership Act; All provisions of the bill. S. 4417: Patent Trial and Appeal Board Reform Act of 2022; All provisions of the bill. S. 4734: Patent Eligibility Restoration Act of 2022; All provisions of the bill.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021; All provisions of the bill. S. 2774: Pride in Patent Ownership Act; All provisions of the bill. S. 4417: Patent Trial and Appeal Board Reform Act of 2022; All provisions of the bill. S. 4734: Patent Eligibility Restoration Act of 2022; All provisions of the bill.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to legislation regarding patents; S. 2891, the Restoring the America Invents Act; S. 4417, Patent Trial and Appeal Board Reform Act of 2022; S. 2774, the Pride in Patent Ownership Act; S. 4704, the Patent Examination and Quality Improvement Act; S. 4734, the Patent Eligibility Restoration Act of 2022; H.R. 7900, S. 4543, the National Defense Authorization Act for Fiscal Year 2023.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Higher Education Act Reauthorization; Department of Education's Notice of Proposed Rulemaking for Certification Procedures; FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs).; Issues related to research funding for the Regional Technology and Innovation Hub program, cybersecurity, concreate, toxic exposure in veterans, additive manufacturing.; The SBIR and STTR Extension Act of 2022 (S. 4900); the Vieques Recovery and Redevelopment Act (S. 405/HR 1317); the Patent Trial and Appeal Board Reform Act of 2022 (S. 4417); the Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); COMPETES Act (H.R. 4521)/Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act (H.R. 4346); the Honoring our PACT Act of 2022 (H.R. 3967); and the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328).

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Intellectual property and patent eligibility, generally, and specifically, with respect to interaction between intellectual property and competition policy. H.R.2873/S.1435 - Affordable Prescriptions for Patients Through Promoting Competition Act of 2021. Issues related to Patent Trial Appeals Board. S.4417 - Patent Trial and Appeal Board Reform Act of 2022.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Protection of inter partes review process to invalidate improperly granted patents. S. 2891 - Restoring the America Invents Act S. 4417 - PTAB Reform Act

Client expense: Not reported · Firm income: $30,000

Government targets: SENATE

S.1435 Affordable Prescriptions for Patients Act H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S 2891 Restore the America Invents Act S. 2774 - Pride in Patent Ownership Act S. 4704 - Patent Examination and Quality Improvement Act of 2022 S. 4417 - Patent Trial and Appeal Board Reform Act of 2022 S. 4430 - Interagency Patent Coordination and Improvement Act of 2022 FTC related issues Issues related to the Patent Act Issues related to march-in/Bayh Dole, WTO/TRIPS waiver, no specific bill

Client expense: $2,140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General patent issues. S.3772 - Defending American Courts Act. S.4417 - Patent Trial and Appeal Board Reform Act of 2022 (PTAB Reform Act of 2022). H.R.8152 - American Data Privacy and Protection Act.

Client expense: $150,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Telecommunications & Information Administration (NTIA), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)

S 4417: Patent Trial and Appeal Board (PTAB) Reform Act of 2022

Client expense: $1,061,778 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Data Privacy, Spectrum, 5G, Aviation, Anti-Trust, Infrastructure, and TSCA related issues; S.516, Advanced Air Mobility Coordination and Leadership Act; H.R.1816, Information Transparency & Personal Data Control Act; H.R.5184, Advancing Americas Interests Act; H.R.8152, American Data Privacy and Protection Act; H.R.5376, Inflation Reduction Act; FY2023 National Defense Authorization Act (H.R.7900, S.4543); Right to Repair; S.3663, Kids Online Safety Act; S.4241, INDEX Act; S.4417, Patent Trial and Appeal Board Reform Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021; All provisions of the bill. S. 2774: Pride in Patent Ownership Act; All provisions of the bill. S. 4417: Patent Trial and Appeal Board Reform Act of 2022; All provisions of the bill. S. 4734: Patent Eligibility Restoration Act of 2022; All provisions of the bill.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021; All provisions of the bill. S. 2774: Pride in Patent Ownership Act; All provisions of the bill. S. 4417: Patent Trial and Appeal Board Reform Act of 2022; All provisions of the bill. S. 4734: Patent Eligibility Restoration Act of 2022; All provisions of the bill.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021; All provisions of the bill. S. 2774: Pride in Patent Ownership Act; All provisions of the bill. S. 4417: Patent Trial and Appeal Board Reform Act of 2022; All provisions of the bill. S. 4734: Patent Eligibility Restoration Act of 2022; All provisions of the bill.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to federal spectrum policy; H.R. 5378/S. 4417 Spectrum Innovation Act of 2021; H.R. 2617, Consolidated Appropriations Act 2023

Client expense: Not reported · Firm income: $60,000

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Issues related to Patents, International Trade Commission H.R. 5184 - Advancing America's Interests Act - All provisions S. 4417 - Patent Trial and Appeal Board Reform Act - All Provisions

Client expense: $170,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Antitrust Legislation ---S.225: Competition and Antitrust Law Enforcement Reform Act of 2021 Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act ---March-In Rights Compulsory Licensing ---H.R.2148/S.909: Prescription Drug Price Relief Act ---H.R.4811: Medicare Negotiation and Competitive Licensing Act Coronavirus (COVID-19) Pandemic ---Restrictions on Intellectual Property Rights ---TRIPS Waiver Data Privacy Issues ---H.R.8152: American Data Privacy and Protection Act ---S.2499: Setting an American Framework to Ensure Data Access, Transparency, and Accountability (SAFE DATA) Act Diversity in Patenting ---H.R.1723/S.632: Inventor Diversity for Economic Advancement (IDEA) Act of 2021 Drug Patenting ---H.R.2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 ---H.R.2883/S.1485: Stop Stalling Access to Affordable Medications ---H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2021 ---H.R.2891/S.1428: Preserve Access to Affordable Generics and Biosimilars Act ---S.1435: Affordable Prescriptions for Patients Act of 2021 ---S.2773: Unleashing American Innovators Act of 2021 ---S.2774: Pride in Patent Ownership Act ---S.2891: Restoring the America Invents Act ---S.4430: Interagency Patent Coordination and Improvement Act of 2022 ---Restrictions on Intellectual Property Rights Intellectual Property Enforcement ---TRIPS Waiver Inter Partes Review ---H.R.5874: Restoring America's Leadership in Innovation Act ---S.2774: Pride in Patent Ownership Act ---S.2891: Restoring the America Invents Act ---Implementation of the America Invents Act of 2011 ---Support Technology and Research for Our Nations Growth and Economic Resilience (STRONGER) Patents Act (Discussion Draft) Patent Reform ---S.4417: Patent Trial and Appeal Board Reform Act of 2022 ---S.4430: Interagency Patent Coordination and Improvement Act of 2022 ---Patent Litigation Reform Patenting of Biological Inventions ---35 USC Section 101 on Patent Eligibility ---Section 101 Modernization Patenting of Humanitarian Technologies ---H.R.5796: Patents for Humanity Act of 2021 United States-Mexico-Canada Agreement (USMCA) ---Mexico Draft Decree Banning Genetically Modified Corn

Client expense: $3,740,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

Bills -S. 4417 Patent Trial and Appeal Board Reform Act -S. 4734 Patent Eligibility Restoration Act -S. 1435 - Affordable Prescriptions for Patients Act of 2021 -H.R. 2873 Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 -H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act Issues -Intellectual property and process patent issues -Patent litigation reforms -PTAB and IPR processes -Section 101 Reform -Domestic and international compulsory licensing issues -March-in Rights

Client expense: $1,630,000 · Firm income: Not reported

Government targets: Patent & Trademark Office (PTO), U.S. Trade Representative (USTR)

S. 4417 Patent Trial and Appeal Board Reform Act

Client expense: $78,000 · Firm income: Not reported

Government targets: SENATE

S. 4704, the Patent Examination and Quality Improvement Act of 2022 S. 4417, the PTAB Reform Act S. 4430, the Interagency Patent Coordination and Improvement Act of 2022. S. 3880, the SMART Copyright Act of 2022 S. 3772, the Defending American Courts Act H.R. 6769, the Pro Codes Act H.R. 6570, the REPAIR Act H.R. 5902, the CLEAR Patents Act of 2021 H.R. 5874, Restoring Americas Leadership in Innovation Act of 2021 S. 2774, Pride in Patent Ownership S. 2773, Unleashing American Innovators Act S. 2891, the Restoring the America Invents Act H.R. 5184, the Advancing Americas Interests Act H.R. 5374, the SHOP SAFE Act S, 3549, the Agricultural Right to Repair Act H.R. 4006 the Fair Repair Act H.R. 3978, To make it unlawful to send a demand letter in bad faith for a patent relating to COVID-19 related products H.R. 3429, the SHOP SAFE Act S. 1843, the SHOP SAFE Act S. 2067, the SECRETS Act S. 1924, the Protecting IP Act of 2021 S. 1294, the Protecting American Intellectual Property Act of 2021 S. 1245, CCP Trade Secrets Act S. 1159, To enhance the authority of U.S. Customs and Border Protection to share information S. 936, the INFORM Consumers Act H.R. 1367/S. 483, the Workforce Mobility Act of 2021 H.R. 1723/S. 632, IDEA Act H.R. 653, Research Advancing to Market Production for Innovators Act H.R. 192, Targeting Rogue and Opaque Letters Act H.R. 597, the Pandemic Treatment Access and Affordability Act of 2021 H.R. 153, Protecting Consumer Access to Generic Drugs Act of 2021 H.R. 704/S. 169, the ARTS Act H.R. 824, the Stop Chinas IP Theft Act S. 39, Protecting American Innovation and Development Act of 2021 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request H.R. 4505, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022

Client expense: Not reported · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office

U.S. Innovation and Competition Act of 2021 (S. 1260), COMPETES Act (H.R. 4521), and Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science ACT (H.R. 4346) - provided comments on innovation, regional technology hub program, and technology transfer provisions. Department of Education's Notice of Proposed Rulemaking for Certification Procedures; The SBIR & STTR Extension Act of 2022 (S. 4900); Patent Trial and Appeal Board Reform Act of 2022 (S. 4417); Honoring our PACT Act of 2022 (H.R. 3967) - toxic exposure in veterans; the Vieques Recovery and Redevelopment Act (S. 405, H.R. 1317). Consolidated Appropriations Act of 2023 (H.R. 2617/P.L. 117-328) - issues related to cybersecurity, concrete and additive manufacturing.

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2891 -- Restoring the America Invents Act -- a bill to amend Title 35 USC to address matters related to the Patent Trial and Appeals Board -- overall S. 2774 -- Pride in Patent Ownership Act -- overall S. 2773 -- Unleashing American Innovation Act -- overall H.R. 5874 -- Restoring American Leadership in Innovaction Act -- overall S. 4417 -- Patent Trial and Appeals Board Reform Act -- overall S. 4543 -- National Defense Authorization Act -- regarding potential amendments related to patents S. 4734 -- Patent Eligibility Restoration Act -- overall S. 4430 -- Interagency Patent Coordination and Improvement Act -- overall S. 4704 -- Patent Examination and Quality Improvement Act -- overall Discussions on issue of march-in rights, PTAB reform overall, need for Section 101 reform

Client expense: Not reported · Firm income: $9,000

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

STRONGER Patents Act National Institute of Standards and Technology (NIST) proposed revisions to Rights to Inventions Made by Nonprofit Organizations and Small Business Firms under Government Grants, Contracts, and Cooperative Agreements and Licensing of Government-Owned Inventions (NIST Docket No. 201207-0327) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions H.R. 3035/S. 1683 (Preventing Foreign Attempts to Erode Healthcare Innovation Act) S. 1260 (Endless Frontier Act/United States Innovation and Competition Act) patent and intellectual property-related provisions and amendments H.R. 4521 (America COMPETES Act) H.R. 4792 (Countering Communist China Act) patent and intellectual property-related provisions H.R. 1934 (Promoting United States International Leadership in 5G Act) standards development for standards-essential patents and innovation Request for Information Regarding Patent Eligibility Jurisprudence Study (Docket No. PTO-P-2021-0032) Bayh-Dole Act march-in misuse demands, including opposition to KEI petition to Health & Human Services to march in on Astellas patents on Xtandi Bayh-Dole Act exceptions to statutory licensing provisions, unilaterally imposed by Energy Dept. requiring DOE review of all licensing agreements grantees negotiate in technology transfers
Patent & Trademark Office/PTAB discretion to institute or to deny trials before the Patent Trial and Appeal Board, pursuant to America Invents Act discretion; PTAB designation of precedential opinions, including the Fintiv doctrine to avoid duplicative litigation on the same patent claims in multiple forums S. 2891 (Restoring the America Invents Act) S. 2774 (Pride in Patent Ownership Act) H.R. 5874 (Restoring Americas Leadership in Innovation Act) Patent Trial and Appeal Board amicus re OpenSky Industries LLC v. VLSI Technology LLC (Case No. IPR2021-01064) Draft Policy Statement on Licensing Negotiations and Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments (Docket No. ATR-2021-0001) Patent eligibility/Section 101 Access to injunctive relief against patent infringers Patent Trial and Appeal Board amicus re Palo Alto Networks Inc. v. Centripetal Networks Inc. (Case No. IPR2022-00182) Patent Trial and Appeal Board amicus re OpenSky Industries LLC and Intel Corp.v. VLSI Technology LLC (Case No. IPR2021-01064) and Patent Quality Assurance LLC and Intel Corp. v. VLSI Technology LLC (Case No. IPR2021-01229) S. 3772 (Defending American Courts Act) S. 4417 (PTAB Reform Act) S. 4430 (Interagency Patent Coordination and Improvement Act) S. 4704 (Patent Examination and Quality Improvement Act) S. 4734 (Patent Eligibility Restoration Act) Request for Comments Regarding the Patent Subject Matter Eligibility Guidance (Docket No. PTO-P-2022-0026) Patent Trial and Appeal Board amicus re Samsung Electronics Co. v. Netlist, Inc. (Case No. IPR2022-00615) H.R. 2617 (legislative vehicle for the Consolidated Appropriations Act FY 2023 with Senate amendment #6552) potential patent-related policy riders

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE

Issues related to intellectual property, data exclusivity, patent eligibility & patent law reform S. 4417, the PTAB Reform Act TRIPS IP Waiver Issues related to manufacturer patent protections at the World Health Organization

Client expense: $930,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2148: Prescription Drug Price Relief Act of 2021 - Provisions related to prescription drug pricing and march-in rights H.R. 2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 - Provisions related to intellectual property and patents H.R. 2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act - Provisions related to patent infringement H.R. 2891: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements H.R. 5635: Intellectual Property Violators Accountability and Transparency Act - Provisions related to intellectual property protections H.R. 5874: Restoring Americas Leadership in Innovation Act of 2021 - Provisions related to intellectual property protections S. 415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity (Public Law 117-9) - Provisions related to FDA policy and exclusivity S. 1428: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements S. 1435: Affordable Prescriptions for Patients Act of 2021 - Provisions related to intellectual property and patents S. 2773: Unleashing American Innovators Act or 2021 - Provisions related to USPTO policy S. 2774: Pride in Patent Ownership Act - Provisions related to patent transparency S. 2891: Restoring the America Invents Act - A bill to amend title 35, United States Code, to address matters relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 2910: Expanding Access to Low-Cost Generics Act of 2021 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes S. 4417: Patent Trial and Appeal Board Reform Act of 2022 - To amend title 35, United States Code, to address matter relating to the Patent Trial and Appeal Board of the United States Patent and Trademark Office, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Biopharmaceutical innovation and patent policy issues Bayh-Dole march-in rights policy issues

Client expense: $1,390,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

General patent issues. S.3772 - Defending American Courts Act. S.4417 - Patent Trial and Appeal Board Reform Act of 2022 (PTAB Reform Act of 2022).

Client expense: $230,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)

H.R. 5874 - Restoring Americas Leadership in Innovation Act (RALIA) H.R. 8697 - Unleashing American Innovators Act H.R. 1723 - Inventor Diversity for Economic Advancement (IDEA) Act S. 2774 - Pride in Patent Ownership Act S.4734 - Patent Eligibility Restoration Act of 2022 S.2773 - Unleashing American Innovators Act S.632 - Inventor Diversity for Economic Advancement (IDEA) Act S.4704 - Patent Examination and Quality Improvement Act S.4417 - Patent Trial and Appeal Board (PTAB) Reform Act -- regarding policy issues affecting higher education institutions and their faculty and students

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Proposals related to music licensing issues, including the development of a new federal music-licensing framework and the preservation of the ASCAP and BMI consent decrees. H.R. 963/S. 505, FAIR Act. S. 2891, Restoring the America Invents Act. Main Street Business Protection Act (draft legislation). S. 4417, Patent Trial and Appeal Board Reform Act of 2022. Freedom of Information Act.

Client expense: $700,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 4417 Patent Trial and Appeal Board Reform Act S. 4734 Patent Eligibility Restoration Act S. 1435 - Affordable Prescriptions for Patients Act of 2021 H.R. 2873 Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act -Intellectual property and process patent issues -Patent litigation reforms -PTAB and IPR processes -Section 101 Reform -Domestic and international compulsory licensing issues -March-in Rights

Client expense: $2,430,000 · Firm income: Not reported

Government targets: Patent & Trademark Office (PTO), U.S. Trade Representative (USTR)

Issues related to intellectual property, data exclusivity, patent eligibility & patent law reform S. 4417, the PTAB Reform Act TRIPS IP Waiver Issues related to manufacturer patent protections at the World Health Organization

Client expense: $910,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE